Avapro and Hyperglycemia - a phase IV clinical study of FDA data

Summary:

Hyperglycemia is reported as a side effect among people who take Avapro (irbesartan), especially for people who are male, 60+ old, have been taking the drug for 10+ years also take Lipitor, and have Type 2 diabetes.

The phase IV clinical study analyzes which people have Hyperglycemia when taking Avapro. It is created by eHealthMe based on reports of 18,804 people who have side effects when taking Avapro from the FDA, and is updated regularly.

What is Avapro?

Avapro has active ingredients of irbesartan. It is often used in high blood pressure. eHealthMe is studying from 19,840 Avapro users. Check the latest studies of Avapro.

What is Hyperglycemia?

Hyperglycemia (high blood sugar) is found to be associated with 1,656 drugs and 2,496 conditions by eHealthMe. Check the latest studies of Hyperglycemia.

On Jul, 09, 2026

18,804 people reported to have side effects when taking Avapro.
Among them, 79 people (0.42%) have Hyperglycemia.

Among these 79 people:

How long have people been on Avapro when they have Hyperglycemia? *

What is the gender of people who have Hyperglycemia when taking Avapro? *

female: 47.44 %
male: 52.56 %

What is the age of people who have Hyperglycemia when taking Avapro? *

What are other drugs people take besides Avapro? *

What are other side effects people have besides Hyperglycemia? *

Weakness: 17 people, 21.52%
Constipation: 15 people, 18.99%
Dehydration (dryness resulting from the removal of water): 15 people, 18.99%
Fatigue (feeling of tiredness): 13 people, 16.46%
Fall: 13 people, 16.46%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 12 people, 15.19%
Memory Loss: 12 people, 15.19%
Hypoglycemia (low blood sugar): 11 people, 13.92%
Sinusitis (inflammation of sinus): 11 people, 13.92%
Bradycardia (abnormally slow heart action): 11 people, 13.92%

What are the existing conditions these people have? *

Type 2 Diabetes: 9 people, 11.39%
Diabetes: 8 people, 10.13%
Multiple Myeloma (cancer of the plasma cells): 5 people, 6.33%
Depression: 5 people, 6.33%
Bipolar Disorder (mood disorder): 5 people, 6.33%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 3 people, 3.80%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 3.80%
Osteoporosis (bones weak and more likely to break): 3 people, 3.80%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 2.53%
Dyslipidaemia (abnormal amount of lipids): 2 people, 2.53%

* Approximation only. Some reports may have incomplete information.

Do you take Avapro and have Hyperglycemia?

- Check whether Hyperglycemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Avapro:

Avapro (19,840 reports)

Hyperglycemia treatments and more:

Hyperglycemia (48,691 reports)

Browse all side effects of Avapro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperglycemia:

Hyperglycemia (1,656 drugs)

Browse all the conditions that are associated with Hyperglycemia:

Hyperglycemia (2,496 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on irbesartan (the active ingredients of Avapro) and Avapro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.